Table 1.

Correlation of miR-23a expression with clinicopathological characteristics in NSCLC

Characteristic	Number of patients	miR-23a high-expression		miR-23a low-expression		P value
		N	%	N	%
Age (years)
≤65	65	34	52.31	31	47.69	0.467
>65	62	31	50.00	31	50.00
Gender
Male	77	35	45.45	42	54.55	0.396
Female	50	30	60.00	20	40.00
Smoking
Yes	89	54	60.67	35	39.33	0.001
No	38	11	28.95	27	71.05
Tumor size (cm)
≤3	41	13	31.71	28	68.29	0.002
>3	86	52	60.47	34	39.53
Lymphnode metastasis
Yes	37	29	78.38	8	21.62	<0.001
No	90	36	40.00	54	60.00
Stage
I/II	85	35	41.18	50	58.82	0.001
III/IV	42	30	71.43	12	28.57
Histologicaltype
Squamous cell carcinoma	64	31	48.44	33	51.56	0.596
Adenocarcinoma	63	34	53.97	29	46.03
Differentiation
Well/Moderate	96	42	43.75	54	56.25	0.004
Poor	31	23	74.19	8	25.81